An integrated national pharmaceutical policy for the United Kingdom?

被引:19
作者
Walley, T [1 ]
Earl-Slater, A
Haycox, A
Bagust, A
机构
[1] Univ Liverpool, Dept Pharmacol & Therapeut, Prescribing Res Grp, Liverpool L69 3GF, Merseyside, England
[2] Univ Birmingham, Dept Commerce, Birmingham B15 2TT, W Midlands, England
关键词
D O I
10.1136/bmj.321.7275.1523
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
[No abstract available]
引用
收藏
页码:1523 / 1526
页数:4
相关论文
共 19 条
[1]  
COLLIER J, 1999, GUARDIAN 1013
[2]  
*COMM DEP HLTH AG, 1999, NAT MED POL 2000
[3]  
DAVIS P, 1997, MANAGING MED PUBLIC
[4]   Too soon to market [J].
Dent, THS ;
Hawke, S .
BMJ-BRITISH MEDICAL JOURNAL, 1997, 315 (7118) :1248-1249
[5]  
*DEP HLTH, 1998, 1 CLASS SERV
[6]  
*DEP HLTH, 1999, PHARM PRIC REG SCHEM
[7]  
*DEP HLTH, 1998, INT GUID VIAGR ISS
[8]  
DYER C, 1997, BRIT MED J, V315, P143
[9]  
Earl-Slater A, 1998, J Manag Med, V12, P5, DOI 10.1108/02689239810225210